Forward Therapeutics CEO Toufike Kanouni (L) and CSO Ewan Taylor

For­ward Ther­a­peu­tics, the first biotech from Curie.Bio, rais­es $50M for oral small mol­e­cules in im­munol­o­gy

An 18-month-old Flori­da biotech has raised a $50 mil­lion Se­ries A to wade in­to the hot im­munol­o­gy and in­flam­ma­tion (I&I) field with oral small mol­e­cules …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.